Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma.
Kinami T, Uchikawa S, Kawaoka T, Yamasaki S, Kosaka M, Johira Y, Yano S, Amioka K, Naruto K, Yamaoka K, Fujii Y, Fujino H, Nakahara T, Ono A, Murakami E, Okamoto W, Yamauchi M, Miki D, Tsuge M, Oka S.
Kinami T, et al. Among authors: fujino h.
Cancer Med. 2024 Mar;13(5):e7025. doi: 10.1002/cam4.7025.
Cancer Med. 2024.
PMID: 38477514
Free PMC article.